Wird geladen...
Maintenance therapy in non-small-cell lung cancer
With standard doublet chemotherapy for patients with advanced non-small-cell lung cancer (NSCLC), we have reached an outcome plateau of about 10 months median overall survival over the last decades. Several studies have now demonstrated some survival benefits for patients treated beyond induction ch...
Gespeichert in:
Veröffentlicht in: | Transl Lung Cancer Res |
---|---|
1. Verfasser: | |
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
Pioneer Bioscience Publishing Company
2012
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4367569/ https://ncbi.nlm.nih.gov/pubmed/25806166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2011.10.02 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|